Vali Aliyev

Progression Patterns as Determinants of Post-Progression Survival in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Treated with Cyclin-Dependent Kinase 4/6 Inhibitors

In patients with HR+/HER2− metastatic breast cancer, the site of first progression after CDK4/6 inhibitor therapy may help estimate subsequent prognosis, and routinely available imaging findings may add practical value when assessing risk after CDK4/6 inhibitor failure.

Concordance between multidisciplinary tumor board decisions and AI-based recommendations in endometrial cancer: impact of discordance direction on clinical outcomes.

Morphological study of Tulipa greigii Regel in the Chatkal range

This study presents a detailed morphological analysis of Tulipa greigii Regel (Liliaceae), a bulbous spring geophyte of high ornamental and conservation value, based on natural populations from the Chatkal Range of the Western Tian Shan, Uzbekistan. Quantitative and qualitative characters of the vegetative and generati...